Royal Bank of Canada’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.79M | Buy |
17,198
+2,487
| +17% | +$716K | ﹤0.01% | 2445 |
|
|
2025
Q4 | $4.46M | Sell |
14,711
-161,380
| -92% | -$50.4M | ﹤0.01% | 2512 |
|
|
2025
Q3 | $49.4M | Buy |
176,091
+24,533
| +16% | +$6.68M | 0.01% | 1026 |
|
|
2025
Q2 | $36.6M | Buy |
151,558
+121,248
| +400% | +$28.7M | 0.01% | 1120 |
|
|
2025
Q1 | $7.38M | Buy |
30,310
+6,100
| +25% | +$1.84M | ﹤0.01% | 1966 |
|
|
2024
Q4 | $7.95M | Buy |
24,210
+725
| +3% | +$246K | ﹤0.01% | 1966 |
|
|
2024
Q3 | $7.86M | Sell |
23,485
-3,894
| -14% | -$1.24M | ﹤0.01% | 1946 |
|
|
2024
Q2 | $7.48M | Sell |
27,379
-4,378
| -14% | -$1.27M | ﹤0.01% | 1873 |
|
|
2024
Q1 | $11M | Sell |
31,757
-851
| -3% | -$280K | ﹤0.01% | 1621 |
|
|
2023
Q4 | $10.5M | Sell |
32,608
-47,649
| -59% | -$14.9M | ﹤0.01% | 1691 |
|
|
2023
Q3 | $28.8M | Buy |
80,257
+1,660
| +2% | +$640K | 0.01% | 964 |
|
|
2023
Q2 | $29.8M | Sell |
78,597
-6,919
| -8% | -$2.82M | 0.01% | 958 |
|
|
2023
Q1 | $41M | Buy |
85,516
+8,228
| +11% | +$3.85M | 0.01% | 764 |
|
|
2022
Q4 | $32.5M | Buy |
77,288
+10,890
| +16% | +$4.4M | 0.01% | 872 |
|
|
2022
Q3 | $27.7M | Buy |
66,398
+9,543
| +17% | +$4.76M | 0.01% | 885 |
|
|
2022
Q2 | $28.1M | Buy |
56,855
+343
| +0.6% | +$179K | 0.01% | 912 |
|
|
2022
Q1 | $31.8M | Buy |
56,512
+6,819
| +14% | +$4.11M | 0.01% | 962 |
|
|
2021
Q4 | $37.5M | Sell |
49,693
-2,787
| -5% | -$2.09M | 0.01% | 995 |
|
|
2021
Q3 | $39.1M | Sell |
52,480
-4,175
| -7% | -$3.13M | 0.01% | 884 |
|
|
2021
Q2 | $36.5M | Buy |
56,655
+5,650
| +11% | +$3.44M | 0.01% | 925 |
|
|
2021
Q1 | $29.1M | Buy |
51,005
+983
| +2% | +$582K | 0.01% | 1032 |
|
|
2020
Q4 | $29.2M | Buy |
50,022
+8,290
| +20% | +$4.72M | 0.01% | 998 |
|
|
2020
Q3 | $21.5M | Buy |
41,732
+7,072
| +20% | +$3.58M | 0.01% | 1031 |
|
|
2020
Q2 | $15.6M | Buy |
34,660
+6,397
| +23% | +$2.82M | 0.01% | 1184 |
|
|
2020
Q1 | $9.91M | Buy |
28,263
+2,254
| +9% | +$829K | ﹤0.01% | 1343 |
|
|
2019
Q4 | $9.63M | Buy |
26,009
+17,745
| +215% | +$6.26M | ﹤0.01% | 1661 |
|
|
2019
Q3 | $2.75M | Buy |
8,264
+1,587
| +24% | +$518K | ﹤0.01% | 2505 |
|
|
2019
Q2 | $2.09M | Buy |
6,677
+798
| +14% | +$239K | ﹤0.01% | 2734 |
|
|
2019
Q1 | $1.8M | Buy |
5,879
+1,415
| +32% | +$382K | ﹤0.01% | 2776 |
|
|
2018
Q4 | $1.03M | Sell |
4,464
-7,552
| -63% | -$2.03M | ﹤0.01% | 3137 |
|
|
2018
Q3 | $3.76M | Buy |
12,016
+10,498
| +692% | +$3.26M | ﹤0.01% | 2342 |
|
|
2018
Q2 | $438K | Buy |
1,518
+735
| +94% | +$203K | ﹤0.01% | 3878 |
|
|
2018
Q1 | $196K | Sell |
783
-292
| -27% | -$74.3K | ﹤0.01% | 4331 |
|
|
2017
Q4 | $257K | Sell |
1,075
-5,191
| -83% | -$1.26M | ﹤0.01% | 4268 |
|
|
2017
Q3 | $1.39M | Buy |
6,266
+2,942
| +89% | +$662K | ﹤0.01% | 2948 |
|
|
2017
Q2 | $752K | Sell |
3,324
-21,936
| -87% | -$4.78M | ﹤0.01% | 3326 |
|
|
2017
Q1 | $5.04M | Buy |
25,260
+23,559
| +1,385% | +$4.54M | ﹤0.01% | 1910 |
|
|
2016
Q4 | $312K | Buy |
1,701
+550
| +48% | +$93.8K | ﹤0.01% | 4164 |
|
|
2016
Q3 | $189K | Sell |
1,151
-5,275
| -82% | -$801K | ﹤0.01% | 4470 |
|
|
2016
Q2 | $919K | Sell |
6,426
-1,559
| -20% | -$222K | ﹤0.01% | 3187 |
|
|
2016
Q1 | $1.09M | Buy |
7,985
+6,414
| +408% | +$842K | ﹤0.01% | 2980 |
|
|
2015
Q4 | $218K | Buy |
1,571
+1,018
| +184% | +$141K | ﹤0.01% | 4457 |
|
|
2015
Q3 | $74K | Buy |
553
+286
| +107% | +$41.2K | ﹤0.01% | 4934 |
|
|
2015
Q2 | $41K | Hold |
267
| – | – | ﹤0.01% | 5327 |
|
|
2015
Q1 | $36K | Sell |
267
-12
| -4% | -$1.49K | ﹤0.01% | 5112 |
|
|
2014
Q4 | $34K | Sell |
279
-3,463
| -93% | -$399K | ﹤0.01% | 5197 |
|
|
2014
Q3 | $424K | Sell |
3,742
-4,460
| -54% | -$528K | ﹤0.01% | 3625 |
|
|
2014
Q2 | $982K | Buy |
8,202
+6,369
| +347% | +$778K | ﹤0.01% | 2856 |
|
|
2014
Q1 | $234K | Sell |
1,833
-2,161
| -54% | -$277K | ﹤0.01% | 3977 |
|
|
2013
Q4 | $495K | Sell |
3,994
-7,537
| -65% | -$918K | ﹤0.01% | 3428 |
|
|
2013
Q3 | $1.36M | Buy |
11,531
+8,814
| +324% | +$1.04M | ﹤0.01% | 2496 |
|
|
2013
Q2 | $305K | Buy |
+2,717
| New | +$319K | ﹤0.01% | 3563 |
|
Other funds holding BIO
VCM
VPM
AI
Royal Bank of Canada's BIO Position: Q1 2026 in Review
Royal Bank of Canada increased its Bio-Rad Laboratories Class A (BIO) stake by 17% in Q1 2026, buying an estimated $716K and bringing the position to 17,198 shares worth $4.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2445.
Royal Bank of Canada first reported a position in BIO in Q2 2013 and has held it in 52 quarters since. The position peaked at $49.4M in Q3 2025. 392 funds tracked by Wall St. Rank hold BIO as of Q1 2026.
- Royal Bank of Canada held 17,198 shares of Bio-Rad Laboratories Class A worth $4.79M as of Q1 2026.
- Royal Bank of Canada bought 2,487 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $716K.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2445 holding.
- Royal Bank of Canada first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Bio-Rad Laboratories Class A position peaked at $49.4M in Q3 2025.
- 392 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.